Abstract
In recent years, the role of T cells, dentritic antigen presenting cells (APCs) and cytokine network in inflammatory dermatoses has been more completely understood. This in turn has enabled the completion of new potentials and goals in immunotherapy. As research in Immunodermatology increased, newly targeted treatments for immunodisfunction were also developed. These treatments were not only beneficial for the patient, but also created experimental tools for better understanding disease pathophysiology and for rethinking nosology. In Dermatology, especially psoriasis treatment, targeted biologic treatment methods have been developed. Immunobiologic treatments can be defined by the therapeutic agents produced by the organisms by using recombination biotechnology. This article will briefly discuss the general characteristics of immunobiologic agents.
Keywords: Biologic agents, dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Immunobiologic Agents in Dermatology
Volume: 6 Issue: 3
Author(s): Neslihan sendur
Affiliation:
Keywords: Biologic agents, dermatology
Abstract: In recent years, the role of T cells, dentritic antigen presenting cells (APCs) and cytokine network in inflammatory dermatoses has been more completely understood. This in turn has enabled the completion of new potentials and goals in immunotherapy. As research in Immunodermatology increased, newly targeted treatments for immunodisfunction were also developed. These treatments were not only beneficial for the patient, but also created experimental tools for better understanding disease pathophysiology and for rethinking nosology. In Dermatology, especially psoriasis treatment, targeted biologic treatment methods have been developed. Immunobiologic treatments can be defined by the therapeutic agents produced by the organisms by using recombination biotechnology. This article will briefly discuss the general characteristics of immunobiologic agents.
Export Options
About this article
Cite this article as:
Neslihan sendur , Immunobiologic Agents in Dermatology, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (3) . https://dx.doi.org/10.2174/187152307781368238
DOI https://dx.doi.org/10.2174/187152307781368238 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proline-Directed Protein Kinase FA as a Potential Target for Diagnosis and Therapy of Human Cancers
Current Cancer Drug Targets Gap Junction Synthesis and Degradation as Therapeutic Targets
Current Drug Targets Auraptene: A Natural Biologically Active Compound with Multiple Targets
Current Drug Targets Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors
Current Drug Delivery Versatile Applications of microRNA in Anti-Cancer Drug Discovery: From Therapeutics to Biomarkers
Current Drug Discovery Technologies Ideal and Reality: Barricade in the Delivery of Small Interfering RNA for Cancer Therapy
Current Pharmaceutical Biotechnology Non-Analgesic Effects of Opioids: Opioids and the Endocrine System
Current Pharmaceutical Design Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems
Current Drug Targets Cyclodextrins for Non-Viral Gene and siRNA Delivery
Pharmaceutical Nanotechnology Central and Peripheral Pain Generators in Women with Chronic Pelvic Pain: Patient Centered Assessment and Treatment
Current Rheumatology Reviews Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments
Current Clinical Pharmacology Targeting Glioblastoma Stem Cells: Cell Surface Markers
Current Medicinal Chemistry A Potential Anticancer Agent 1,2-di(quinazolin-4-yl)diselane
Letters in Drug Design & Discovery In Vivo Biological Evaluation of Ethyl 4-(7-hydroxy-4-methyl-2-oxoquinolin-1- ylamino)-coumarin-3-carboxylate as an Antitumor Agent
Anti-Cancer Agents in Medicinal Chemistry A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds Synthesis and Hypoxia Selective Radiosensitization Potential of β-2-FAZA and β-3-FAZL: Fluorinated Azomycin β-Nucleosides
Medicinal Chemistry Novel Drugs Targeting Microtubules: the Role of Epothilones
Current Pharmaceutical Design Preclinical Development of New Therapy for Glycogen Storage Diseases
Current Gene Therapy Stem Cells as In Vitro Models of Disease
Current Stem Cell Research & Therapy